-
2
-
-
0037125379
-
Risks and benefits of estrogen plus progestin in healthy postmenopausal women: Principal results from the Women's Health Initiative randomized controlled trial
-
Rossouw JE, Anderson GL, Prentice RL, et al: Risks and benefits of estrogen plus progestin in healthy postmenopausal women: Principal results from the Women's Health Initiative randomized controlled trial. JAMA 288:321-333, 2002
-
(2002)
JAMA
, vol.288
, pp. 321-333
-
-
Rossouw, J.E.1
Anderson, G.L.2
Prentice, R.L.3
-
3
-
-
0031859788
-
Pilot evaluation of venlafaxine hydrochloride for the therapy of hot flashes in cancer survivors
-
Loprinzi CL, Pisansky TM, Fonseca R, et al: Pilot evaluation of venlafaxine hydrochloride for the therapy of hot flashes in cancer survivors. J Clin Oncol 16:2377-2381, 1998
-
(1998)
J Clin Oncol
, vol.16
, pp. 2377-2381
-
-
Loprinzi, C.L.1
Pisansky, T.M.2
Fonseca, R.3
-
4
-
-
0034676813
-
Venlafaxine in management of hot flashes in survivors of breast cancer: A randomised controlled trial
-
Loprinzi CL, Kugler JW, Sloan JA, et al: Venlafaxine in management of hot flashes in survivors of breast cancer: A randomised controlled trial. Lancet 356:2059-2063, 2000
-
(2000)
Lancet
, vol.356
, pp. 2059-2063
-
-
Loprinzi, C.L.1
Kugler, J.W.2
Sloan, J.A.3
-
5
-
-
0037087582
-
Phase III evaluation of fluoxetine for treatment of hot flashes
-
Loprinzi CL, Sloan JA, Perez EA, et al: Phase III evaluation of fluoxetine for treatment of hot flashes. J Clin Oncol 20:1578-1583, 2002
-
(2002)
J Clin Oncol
, vol.20
, pp. 1578-1583
-
-
Loprinzi, C.L.1
Sloan, J.A.2
Perez, E.A.3
-
6
-
-
27244436938
-
Paroxetine is an effective treatment for hot flashes: Results from a prospective randomized clinical trial
-
Stearns V, Slack R, Greep N, et al: Paroxetine is an effective treatment for hot flashes: Results from a prospective randomized clinical trial. J Clin Oncol 23:6919-6930, 2005
-
(2005)
J Clin Oncol
, vol.23
, pp. 6919-6930
-
-
Stearns, V.1
Slack, R.2
Greep, N.3
-
7
-
-
0037976797
-
Paroxetine controlled release in the treatment of menopausal hot flashes: A randomized controlled trial
-
Stearns V, Beebe KL, Iyengar M, et al: Paroxetine controlled release in the treatment of menopausal hot flashes: A randomized controlled trial. JAMA 289:2827-2834, 2003
-
(2003)
JAMA
, vol.289
, pp. 2827-2834
-
-
Stearns, V.1
Beebe, K.L.2
Iyengar, M.3
-
8
-
-
33645452564
-
Randomized, double-blind, placebo-controlled, crossover study of sertraline (Zoloft) for the treatment of hot flashes in women with early stage breast cancer taking tamoxifen
-
Kimmick GG, Lovato J, McQuellon R, et al: Randomized, double-blind, placebo-controlled, crossover study of sertraline (Zoloft) for the treatment of hot flashes in women with early stage breast cancer taking tamoxifen. Breast J 12:114-122, 2006
-
(2006)
Breast J
, vol.12
, pp. 114-122
-
-
Kimmick, G.G.1
Lovato, J.2
McQuellon, R.3
-
9
-
-
13244260690
-
Management of postmenopausal hot flushes with venlafaxine hydrochloride: A randomized, controlled trial
-
Evans ML, Pritts E, Vittinghoff E, et al: Management of postmenopausal hot flushes with venlafaxine hydrochloride: A randomized, controlled trial. Obstet Gynecol 105:161-166, 2005
-
(2005)
Obstet Gynecol
, vol.105
, pp. 161-166
-
-
Evans, M.L.1
Pritts, E.2
Vittinghoff, E.3
-
10
-
-
13444257684
-
Citalopram and fluoxetine in the treatment of postmenopausal symptoms: A prospective, randomized, 8-month, placebo-controlled, double-blind study
-
Suvanto-Luukkonen E, Koivunen R, Sundstrom H, et al: Citalopram and fluoxetine in the treatment of postmenopausal symptoms: A prospective, randomized, 8-month, placebo-controlled, double-blind study. Menopause 12:18-26, 2005
-
(2005)
Menopause
, vol.12
, pp. 18-26
-
-
Suvanto-Luukkonen, E.1
Koivunen, R.2
Sundstrom, H.3
-
11
-
-
33746102870
-
Sertraline to treat hot flashes: A randomized controlled, double-blind, crossover trial in a general population
-
Gordon PR, Kerwin JP, Boesen KG, et al: Sertraline to treat hot flashes: A randomized controlled, double-blind, crossover trial in a general population. Menopause 13:568-575, 2006
-
(2006)
Menopause
, vol.13
, pp. 568-575
-
-
Gordon, P.R.1
Kerwin, J.P.2
Boesen, K.G.3
-
12
-
-
34147132741
-
Ineffectiveness of sertraline for treatment of menopausal hot flushes: A randomized controlled trial
-
Grady D, Cohen B, Tice J, et al: Ineffectiveness of sertraline for treatment of menopausal hot flushes: A randomized controlled trial. Obstet Gynecol 109:823-830, 2007
-
(2007)
Obstet Gynecol
, vol.109
, pp. 823-830
-
-
Grady, D.1
Cohen, B.2
Tice, J.3
-
13
-
-
0034643844
-
Gabapentin's effects on hot flashes and hypothermia
-
Guttuso TJ Jr: Gabapentin's effects on hot flashes and hypothermia. Neurology 54:2161-2163, 2000
-
(2000)
Neurology
, vol.54
, pp. 2161-2163
-
-
Guttuso Jr, T.J.1
-
14
-
-
0036844441
-
Pilot evaluation of gabapentin for treating hot flashes
-
Loprinzi C, Barton D, Sloan J, et al: Pilot evaluation of gabapentin for treating hot flashes. Mayo Clin Proc 77:1159-1163, 2002
-
(2002)
Mayo Clin Proc
, vol.77
, pp. 1159-1163
-
-
Loprinzi, C.1
Barton, D.2
Sloan, J.3
-
15
-
-
0037311026
-
Gabapentin's effects on hot flashes in postmenopausal women: A randomized controlled trial
-
Guttuso T Jr, Kurlan R, McDermott MP, et al: Gabapentin's effects on hot flashes in postmenopausal women: A randomized controlled trial. Obstet Gynecol 101:337-345, 2003
-
(2003)
Obstet Gynecol
, vol.101
, pp. 337-345
-
-
Guttuso Jr, T.1
Kurlan, R.2
McDermott, M.P.3
-
16
-
-
26944497954
-
Gabapentin for hot flashes in 420 women with breast cancer: A randomised double-blind placebo-controlled trial
-
Pandya KJ, Morrow GR, Roscoe JA, et al: Gabapentin for hot flashes in 420 women with breast cancer: A randomised double-blind placebo-controlled trial. Lancet 366:818-824, 2005
-
(2005)
Lancet
, vol.366
, pp. 818-824
-
-
Pandya, K.J.1
Morrow, G.R.2
Roscoe, J.A.3
-
17
-
-
33746896231
-
Gabapentin, estrogen, and placebo for treating hot flushes: A randomized controlled trial
-
Reddy SY, Warner H, Guttuso T Jr, et al: Gabapentin, estrogen, and placebo for treating hot flushes: A randomized controlled trial. Obstet Gynecol 108:41-48, 2006
-
(2006)
Obstet Gynecol
, vol.108
, pp. 41-48
-
-
Reddy, S.Y.1
Warner, H.2
Guttuso Jr, T.3
-
18
-
-
33646188516
-
Nonhormonal therapies for menopausal hot flashes: Systematic review and meta-analysis
-
Nelson HD, Vesco KK, Haney E, et al: Nonhormonal therapies for menopausal hot flashes: Systematic review and meta-analysis. JAMA 295:2057-2071, 2006
-
(2006)
JAMA
, vol.295
, pp. 2057-2071
-
-
Nelson, H.D.1
Vesco, K.K.2
Haney, E.3
-
19
-
-
0035576115
-
Methodologic lessons learned from hot flash studies
-
Sloan JA, Loprinzi CL, Novotny PJ, et al: Methodologic lessons learned from hot flash studies. J Clin Oncol 19:4280-4290, 2001
-
(2001)
J Clin Oncol
, vol.19
, pp. 4280-4290
-
-
Sloan, J.A.1
Loprinzi, C.L.2
Novotny, P.J.3
-
20
-
-
39849093340
-
Initial severity and antidepressant benefits: A meta-analysis of data submitted to the Food and Drug Administration
-
Kirsch I, Deacon BJ, Huedo-Medina TB, et al: Initial severity and antidepressant benefits: A meta-analysis of data submitted to the Food and Drug Administration. PLoS Med 5:260-268, 2008
-
(2008)
PLoS Med
, vol.5
, pp. 260-268
-
-
Kirsch, I.1
Deacon, B.J.2
Huedo-Medina, T.B.3
-
21
-
-
33644639136
-
Pharmacogenetics of tamoxifen biotransformation is associated with clinical outcomes of efficacy and hot flashes
-
Goetz MP, Rae JM, Suman VJ, et al: Pharmacogenetics of tamoxifen biotransformation is associated with clinical outcomes of efficacy and hot flashes. J Clin Oncol 23:9312-9318, 2005
-
(2005)
J Clin Oncol
, vol.23
, pp. 9312-9318
-
-
Goetz, M.P.1
Rae, J.M.2
Suman, V.J.3
-
22
-
-
0346602691
-
Active tamoxifen metabolite plasma concentrations after coadministration of tamoxifen and the selective serotonin reuptake inhibitor paroxetine
-
Stearns V, Johnson M, Rae J, et al: Active tamoxifen metabolite plasma concentrations after coadministration of tamoxifen and the selective serotonin reuptake inhibitor paroxetine. J Natl Cancer Inst 95:1758-1764, 2003
-
(2003)
J Natl Cancer Inst
, vol.95
, pp. 1758-1764
-
-
Stearns, V.1
Johnson, M.2
Rae, J.3
-
23
-
-
67649850757
-
Efficacy of non-estrogenic hot flash therapies among women stratified by breast cancer history and tamoxifen use: A pooled analysis
-
in press
-
Bardia A, Novotny P, Sloan J, et al: Efficacy of non-estrogenic hot flash therapies among women stratified by breast cancer history and tamoxifen use: A pooled analysis. Menopause (in press)
-
Menopause
-
-
Bardia, A.1
Novotny, P.2
Sloan, J.3
-
24
-
-
64049101827
-
Newer antidepressants for hot flashes-should their efficacy still be up for debate?
-
Loprinzi CL, Barton DL, Sloan JA, et al: Newer antidepressants for hot flashes-should their efficacy still be up for debate? Menopause 16:184-187, 2009
-
(2009)
Menopause
, vol.16
, pp. 184-187
-
-
Loprinzi, C.L.1
Barton, D.L.2
Sloan, J.A.3
-
25
-
-
56749090554
-
Gabapentin for hot flashes in men: NCCTG trial N00CB
-
suppl; abstr 9005
-
Loprinzi C: Gabapentin for hot flashes in men: NCCTG trial N00CB. J Clin Oncol 25:494S, 2007 (suppl; abstr 9005)
-
(2007)
J Clin Oncol
, vol.25
-
-
Loprinzi, C.1
-
26
-
-
33846509336
-
Randomized, double-blind, placebo-controlled crossover trials of venlafaxine for hot flashes after breast cancer
-
Carpenter JS, Storniolo AM, Johns S, et al: Randomized, double-blind, placebo-controlled crossover trials of venlafaxine for hot flashes after breast cancer. Oncologist 12:124-135, 2007
-
(2007)
Oncologist
, vol.12
, pp. 124-135
-
-
Carpenter, J.S.1
Storniolo, A.M.2
Johns, S.3
-
27
-
-
52749085160
-
A phase III trial evaluating three doses of citalopram for hot flashes: NCCTG Trial N05C9
-
suppl; abstr 9538, 511s
-
Barton DL, LaVasseur B, Sloan JA, et al: A phase III trial evaluating three doses of citalopram for hot flashes: NCCTG Trial N05C9. J Clin Oncol 26:511s, 2008 (suppl; abstr 9538)
-
(2008)
J Clin Oncol
, vol.26
-
-
Barton, D.L.1
LaVasseur, B.2
Sloan, J.A.3
-
28
-
-
37549033111
-
Efficacy and tolerability of desvenlafaxine succinate treatment for menopausal vasomotor symptoms: A randomized controlled trial
-
Speroff L, Gass M, Constantine G, et al: Efficacy and tolerability of desvenlafaxine succinate treatment for menopausal vasomotor symptoms: A randomized controlled trial. Obstet Gynecol 111:77-87, 2008
-
(2008)
Obstet Gynecol
, vol.111
, pp. 77-87
-
-
Speroff, L.1
Gass, M.2
Constantine, G.3
|